These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31513661)

  • 1. Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant.
    Choi MY; Jee D; Kwon JW
    PLoS One; 2019; 14(9):e0222364. PubMed ID: 31513661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of diabetic macular edema patients with serous retinal detachment.
    Hwang HB; Jee D; Kwon JW
    Medicine (Baltimore); 2019 Dec; 98(51):e18333. PubMed ID: 31860985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema.
    Hillier RJ; Ojaimi E; Wong DT; Mak MYK; Berger AR; Kohly RP; Kertes PJ; Forooghian F; Boyd SR; Eng K; Altomare F; Giavedoni LR; Nisenbaum R; Muni RH
    JAMA Ophthalmol; 2018 Apr; 136(4):382-388. PubMed ID: 29522144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Hwang HS; Chae JB; Kim JY; Kim DY
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular Edema.
    Figueras-Roca M; Sala-Puigdollers A; Zarranz-Ventura J; Alba-Linero C; Alforja S; Esquinas C; Molins B; Adán A
    Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1336-1343. PubMed ID: 30933261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment.
    Kwon JW; Jee D
    PLoS One; 2018; 13(9):e0203408. PubMed ID: 30204781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with the duration of action of dexamethasone intravitreal implants in diabetic macular edema patients.
    Park YG; Choi MY; Kwon JW
    Sci Rep; 2019 Dec; 9(1):19588. PubMed ID: 31862943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants.
    Rübsam A; Wernecke L; Rau S; Pohlmann D; Müller B; Zeitz O; Joussen AM
    J Diabetes Res; 2021; 2021():8820216. PubMed ID: 33937416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema.
    Güler E; Totan Y; Betül Güragaç F
    Cutan Ocul Toxicol; 2017 Jun; 36(2):180-184. PubMed ID: 28366074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Soluble CD14 in the Aqueous Humor and Hyperreflective Foci on Optical Coherence Tomography in Patients With Diabetic Macular Edema.
    Lee H; Jang H; Choi YA; Kim HC; Chung H
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):715-721. PubMed ID: 29392317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
    Shah SU; Harless A; Bleau L; Maturi RK
    Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.
    Busch C; Zur D; Fraser-Bell S; Laíns I; Santos AR; Lupidi M; Cagini C; Gabrielle PH; Couturier A; Mané-Tauty V; Giancipoli E; Ricci GD; Cebeci Z; Rodríguez-Valdés PJ; Chaikitmongkol V; Amphornphruet A; Hindi I; Agrawal K; Chhablani J; Loewenstein A; Iglicki M; Rehak M;
    Acta Diabetol; 2018 Aug; 55(8):789-796. PubMed ID: 29730822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
    Shin YU; Hong EH; Lim HW; Kang MH; Seong M; Cho H
    BMC Ophthalmol; 2017 Oct; 17(1):182. PubMed ID: 28974211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous humor analyses of diabetic macular edema patients with subretinal fluid.
    Kwon JW; Kim B; Jee D; Cho YK
    Sci Rep; 2021 Oct; 11(1):20985. PubMed ID: 34697354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.
    Figueras-Roca M; Sala-Puigdollers A; Alforja S; Torras J; Peraza-Nieves J; Zarranz-Ventura J; Adan Civera A; Molins B
    Ocul Immunol Inflamm; 2019; 27(8):1203-1210. PubMed ID: 31418610
    [No Abstract]   [Full Text] [Related]  

  • 20. Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results.
    Busch C; Fraser-Bell S; Iglicki M; Lupidi M; Couturier A; Chaikitmongkol V; Giancipoli E; Rodríguez-Valdés PJ; Gabrielle PH; Laíns I; Santos AR; Cebeci Z; Amphornphruet A; Degenhardt V; Unterlauft JD; Cagini C; Mané-Tauty V; D'Amico Ricci G; Hindi I; Agrawal K; Chhablani J; Loewenstein A; Zur D; Rehak M;
    Acta Diabetol; 2019 Dec; 56(12):1341-1350. PubMed ID: 31541334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.